Literature DB >> 18538388

Novel HLA-G-binding leukocyte immunoglobulin-like receptor (LILR) expression patterns in human placentas and umbilical cords.

R H McIntire1, T Sifers, J S Platt, K G Ganacias, D K Langat, J S Hunt.   

Abstract

Human placentas are sources of cytokines, hormones and other substances that program receptive cells. One of these substances is HLA-G, which influences the functioning of both leukocytes and endothelial cells. In this study, we investigated the possibility that these and/or other types of cells in extraembryonic fetal tissues might respond to HLA-G by interacting with one or another of the leukocyte immunoglobulin-like receptors (LILR). LILRB1 is expressed by most leukocytes and LILRB2 is expressed primarily by monocytes, macrophages and dendritic cells. Analysis of term placentas by immunohistochemistry and Real Time PCR demonstrated that LILRB1 and LILRB2 protein and specific messages are produced in the mesenchyme of term villous placenta but are differently localized. LILRB1 was abundant in stromal cells and LILRB2 was prominent perivascularly. Neither receptor was identified in trophoblast. Further investigation using double label immunofluorescence indicated that placental vascular smooth muscle but not endothelia exhibit LILRB2. Term umbilical cord exhibited the same LILRB2 patterns as term placenta. Samples obtained by laser capture dissection of vascular smooth muscle in umbilical cords demonstrated LILRB2 mRNA, and double label immunofluorescence showed that cord vascular smooth muscle but not endothelium exhibited LILRB2 protein. The presence of LILRB1 in placental stromal cells and LILRB2 in vascular smooth muscle strongly suggest that HLA-G has novel functions in these tissues that could include regulation of placental immunity as well as development and function of the extraembryonic vasculature.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18538388      PMCID: PMC2505055          DOI: 10.1016/j.placenta.2008.04.007

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  26 in total

Review 1.  The ILT family of leukocyte receptors.

Authors:  D S Allan; A J McMichael; V M Braud
Journal:  Immunobiology       Date:  2000-05       Impact factor: 3.144

Review 2.  Stranger in a strange land.

Authors:  Joan S Hunt
Journal:  Immunol Rev       Date:  2006-10       Impact factor: 12.988

Review 3.  HLA-G and immune tolerance in pregnancy.

Authors:  Joan S Hunt; Margaret G Petroff; Ramsey H McIntire; Carole Ober
Journal:  FASEB J       Date:  2005-05       Impact factor: 5.191

4.  Soluble HLA-G1 inhibits angiogenesis through an apoptotic pathway and by direct binding to CD160 receptor expressed by endothelial cells.

Authors:  Pierre Fons; Sophie Chabot; Judith E Cartwright; Francoise Lenfant; Fatima L'Faqihi; Jerome Giustiniani; Jean-Pascal Herault; Genevieve Gueguen; Françoise Bono; Pierre Savi; Maryse Aguerre-Girr; Sylvie Fournel; François Malecaze; Armand Bensussan; Jean Plouët; Philippe Le Bouteiller
Journal:  Blood       Date:  2006-06-29       Impact factor: 22.113

5.  Decidual macrophages are potentially susceptible to inhibition by class Ia and class Ib HLA molecules.

Authors:  Margaret G Petroff; Peter Sedlmayr; Dagmar Azzola; Joan S Hunt
Journal:  J Reprod Immunol       Date:  2002 Jul-Aug       Impact factor: 4.054

6.  Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G.

Authors:  Mitsunori Shiroishi; Kouhei Tsumoto; Kimie Amano; Yasuo Shirakihara; Marco Colonna; Veronique M Braud; David S J Allan; Azure Makadzange; Sarah Rowland-Jones; Benjamin Willcox; E Yvonne Jones; P Anton van der Merwe; Izumi Kumagai; Katsumi Maenaka
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-09       Impact factor: 11.205

7.  HLA-G, pre-eclampsia, immunity and vascular events.

Authors:  Philippe Le Bouteiller; Nathalie Pizzato; Aliz Barakonyi; Corinne Solier
Journal:  J Reprod Immunol       Date:  2003-08       Impact factor: 4.054

8.  Placental cell expression of HLA-G2 isoforms is limited to the invasive trophoblast phenotype.

Authors:  Pedro J Morales; Judith L Pace; Jeralyn Sue Platt; Teresa A Phillips; Kim Morgan; Asgi T Fazleabas; Joan S Hunt
Journal:  J Immunol       Date:  2003-12-01       Impact factor: 5.422

9.  Alloantigen specific CD8+CD28- FOXP3+ T suppressor cells induce ILT3+ ILT4+ tolerogenic endothelial cells, inhibiting alloreactivity.

Authors:  John S Manavalan; Seunghee Kim-Schulze; Luigi Scotto; Afzal J Naiyer; George Vlad; Paolo C Colombo; Charles Marboe; Donna Mancini; Raffaello Cortesini; Nicole Suciu-Foca
Journal:  Int Immunol       Date:  2004-06-28       Impact factor: 4.823

10.  Analysis of the soluble isoforms of HLA-G mRNAs and proteins.

Authors:  Judith L Pace; Pedro J Morales; Teresa A Phillips; Joan S Hunt
Journal:  Methods Mol Med       Date:  2006
View more
  18 in total

Review 1.  The importance of HLA-G expression in embryos, trophoblast cells, and embryonic stem cells.

Authors:  Roberta Rizzo; Martine Vercammen; Hilde van de Velde; Peter A Horn; Vera Rebmann
Journal:  Cell Mol Life Sci       Date:  2010-11-16       Impact factor: 9.261

Review 2.  LILRB receptor-mediated regulation of myeloid cell maturation and function.

Authors:  William van der Touw; Hui-Ming Chen; Ping-Ying Pan; Shu-Hsia Chen
Journal:  Cancer Immunol Immunother       Date:  2017-06-21       Impact factor: 6.968

Review 3.  Leukocyte immunoglobulin-like receptors in human diseases: an overview of their distribution, function, and potential application for immunotherapies.

Authors:  Jilu Zhang; Sunny Mai; Hui-Ming Chen; Kyeongah Kang; Xian Chang Li; Shu-Hsia Chen; Ping-Ying Pan
Journal:  J Leukoc Biol       Date:  2017-03-28       Impact factor: 4.962

Review 4.  New Targets for Antiviral Therapy: Inhibitory Receptors and Immune Checkpoints on Myeloid Cells.

Authors:  Yanni Liu; Paul Nicklin; Yuan He
Journal:  Viruses       Date:  2022-05-25       Impact factor: 5.818

5.  Natural LILRB1 D1-D2 variants show frequency differences in populations and bind to HLA class I with various avidities.

Authors:  Fuguo Liu; Alexander T H Cocker; Jason L Pugh; Zakia Djaoud; Peter Parham; Lisbeth A Guethlein
Journal:  Immunogenetics       Date:  2022-05-13       Impact factor: 3.330

6.  Identification of natural killer cell receptor genes in the genome of the marsupial Tasmanian devil (Sarcophilus harrisii).

Authors:  Lauren E van der Kraan; Emily S W Wong; Nathan Lo; Beata Ujvari; Katherine Belov
Journal:  Immunogenetics       Date:  2012-09-25       Impact factor: 2.846

Review 7.  Regulation of T-cell immunity by leucocyte immunoglobulin-like receptors: innate immune receptors for self on antigen-presenting cells.

Authors:  Katie J Anderson; Rachel L Allen
Journal:  Immunology       Date:  2009-05       Impact factor: 7.397

8.  LILRA3 binds both classical and non-classical HLA class I molecules but with reduced affinities compared to LILRB1/LILRB2: structural evidence.

Authors:  Myongchol Ryu; Yong Chen; Jianxun Qi; Jun Liu; Zheng Fan; Gol Nam; Yi Shi; Hao Cheng; George F Gao
Journal:  PLoS One       Date:  2011-04-29       Impact factor: 3.240

Review 9.  HLA-G Orchestrates the Early Interaction of Human Trophoblasts with the Maternal Niche.

Authors:  Silvia Gregori; Giada Amodio; Federica Quattrone; Paola Panina-Bordignon
Journal:  Front Immunol       Date:  2015-03-30       Impact factor: 7.561

Review 10.  Molecular signatures of T-cell inhibition in HIV-1 infection.

Authors:  Marie Larsson; Esaki M Shankar; Karlhans F Che; Alireza Saeidi; Rada Ellegård; Muttiah Barathan; Vijayakumar Velu; Adeeba Kamarulzaman
Journal:  Retrovirology       Date:  2013-03-20       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.